Your session is about to expire
← Back to Search
Pacemaker
Aveir VR Leadless Pacemaker for Arrhythmia
N/A
Waitlist Available
Research Sponsored by Abbott Medical Devices
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
Summary
This trial is testing the safety and effectiveness of the Aveir LP System, a pacemaker for patients with slow heart rhythms. The device helps the heart maintain a regular beat by sending electrical signals.
Eligible Conditions
- Arrhythmia
- Slow Heart Rate
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Trial Design
1Treatment groups
Experimental Treatment
Group I: Aveir VR Leadless PacemakerExperimental Treatment1 Intervention
VVIR pacing
Find a Location
Who is running the clinical trial?
Abbott Medical DevicesLead Sponsor
647 Previous Clinical Trials
408,208 Total Patients Enrolled
18 Trials studying Arrhythmia
10,434 Patients Enrolled for Arrhythmia
Share this study with friends
Copy Link
Messenger